Results 181 to 190 of about 20,750 (203)

Dabrafenib

Reactions Weekly, 2021
  +4 more sources

Dabrafenib

Reactions Weekly, 2023
openaire   +2 more sources

Dabrafenib

Reactions Weekly, 2018
  +6 more sources

Dabrafenib

Reactions Weekly, 2019
  +6 more sources

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Nature Medicine, 2023
Vivek Subbiah, Ulrik Lassen, J-Y Blay
exaly  

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

Lancet Oncology, The, 2022
Alexander Stein, Martin J B Van Den Bent, Jacques De Greve   +2 more
exaly  

Dabrafenib/dabrafenib/trametinib

Reactions Weekly, 2018
openaire   +1 more source

Recent developments in the medical and surgical treatment of melanoma

Ca-A Cancer Journal for Clinicians, 2014
Jonathan S Zager
exaly  

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Lancet, The, 2012
Axel Hauschild, Jean-Jacques Grob, Ralf Gutzmer   +2 more
exaly  

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Lancet, The, 2015
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly